title: Medical and social outcome in adolescents with end-stage renal failure.
abstract: Clinical information was collected on 118 adolescents who developed ESRF at age 143 months or older and were treated between 1966 and 1986 at the Toronto Hospital for Sick Children. The cumulative survival rate in transplanted patients (N = 109) was 80.1% after 15 years. Survival rates after four years were 93.9% in transplanted and 46.9% in nontransplanted patients (P less than 0.001). No patient receiving dialysis alone (N = 9) was followed longer than four years. Nine patients received three transplants and had an 89% survival rate. Six of these had a functioning graft at end of the follow-up. The cumulative survival of the entire group was 76.4% at eighteen years. Forty-two (35.6%) patients had a height below the third percentile. Functional status obtained by a structure telephone interview with a member of the present treating nephrology service was good (G) or excellent (E) for 66.7% of all patients (73.5% of transplant patients (N = 68) and 45% of dialysis patients (N = 20). Hemodialysis patients functioned less well [25% G/E (N = 12)] than peritoneal dialysis patients [75% G/E (N = 8)]. Most patients achieved an appropriate level of formal education although more slowly than normal adolescents. Only 11 patients were neither enrolled in an educational institution nor employed. We conclude that aggressive treatment for adolescents with ESRF is an appropriate application of health care resources.
authors.affiliation: Division of Nephrology, Wellesley Hospital, Toronto, Ontario, Canada.
authors.forename: J M
authors.initials: JM
authors.lastname: Roscoe
authors.forename: L F
authors.initials: LF
authors.lastname: Smith
authors.forename: E A
authors.initials: EA
authors.lastname: Williams
authors.forename: M
authors.initials: M
authors.lastname: Stein
authors.forename: A R
authors.initials: AR
authors.lastname: Morton
authors.forename: J W
authors.initials: JW
authors.lastname: Balfe
authors.forename: G S
authors.initials: GS
authors.lastname: Arbus
mesh_terms: D000293:Adolescent; D005500:Follow-Up Studies; D006130:Growth Disorders / Q000209:etiology; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality* / Q000523:psychology / Q000628:therapy; D009017:Morbidity; D009864:Ontario / Q000453:epidemiology; D011379:Prognosis; D011788:Quality of Life; D015996:Survival Rate